COMMUNIQUÉS West-GlobeNewswire

-
Treace to Report Second Quarter 2024 Financial Results on August 6, 2024
18/07/2024 -
Profound Medical to Release Second Quarter 2024 Financial Results on August 8 – Conference Call to Follow
18/07/2024 -
Stereotaxis Strengthens Board of Directors with Appointment of Nachum Shamir
18/07/2024 -
LifeStance to Host Second Quarter 2024 Earnings Conference Call on August 8, 2024
18/07/2024 -
Codexis to Report Second Quarter 2024 Financial Results on August 8
18/07/2024 -
Sight Sciences to Report Second Quarter Financial Results on August 1, 2024
18/07/2024 -
Mangoceuticals CEO Jacob Cohen Featured on Benzinga All-Access
18/07/2024 -
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
18/07/2024 -
Intuitive Announces Second Quarter Earnings
18/07/2024 -
Crinetics Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 8, 2024
18/07/2024 -
Seer to Report Second Quarter 2024 Financial Results on August 8, 2024
18/07/2024 -
WW International, Inc. Schedules Second Quarter 2024 Earnings Conference Call
18/07/2024 -
Nymox Annual Report
18/07/2024 -
Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC
18/07/2024 -
Invitation to Idorsia's Half Year 2024 Financial Reporting webcast and conference call
18/07/2024 -
Nika Pharmaceuticals, Inc. (NIKA) Signed a Distribution Agreement for Nigeria
18/07/2024 -
ZyVersa Therapeutics Announces Publication Demonstrating that Inflammasome ASC Inhibitor IC 100 Restored Retinal Structure and Function in a Retinopathy of Prematurity Animal Model
18/07/2024 -
Signati Medical Announces Completion of Enrollment in First-in-Human Clinical Trial for Groundbreaking Sealed Vasectomy Procedure
18/07/2024 -
Alkeus Pharmaceuticals Announces Presentation of a TEASE-3 Study Update Showing Progression Stalled in Early-Stage Stargardt Disease Patients Treated with Gildeuretinol
18/07/2024
Pages